SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

06 Aug 2025 Evaluate
The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3912.84 millions.The company reported a drastic decline of -77.00% in the quarter ended June 2025 to Rs. 80.61  millions from Rs. 350.50 millions  .The Operating Profit of the company witnessed a decrease to 230.44 millions from 516.82 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3912.84 3856.43 1.46 3912.84 3856.43 1.46 15545.35 15375.94 1.10
Other Income 40.92 30.72 33.20 40.92 30.72 33.20 157.20 125.66 25.10
PBIDT 230.44 516.82 -55.41 230.44 516.82 -55.41 1691.31 1743.84 -3.01
Interest 38.12 10.44 265.13 38.12 10.44 265.13 71.03 35.09 102.42
PBDT 192.32 506.38 -62.02 192.32 506.38 -62.02 1620.28 1708.75 -5.18
Depreciation 78.79 35.90 119.47 78.79 35.90 119.47 244.42 219.00 11.61
PBT 113.53 470.48 -75.87 113.53 470.48 -75.87 1375.86 1489.75 -7.64
TAX 32.92 119.98 -72.56 32.92 119.98 -72.56 360.10 380.40 -5.34
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 47.27 -4.36 -1184.17
PAT 80.61 350.50 -77.00 80.61 350.50 -77.00 1015.76 1109.35 -8.44
Equity 1095.84 1022.27 7.20 1095.84 1022.27 7.20 1095.84 1022.27 7.20
PBIDTM(%) 5.89 13.40 -56.05 5.89 13.40 -56.05 10.88 11.34 -4.07

Morepen Laboratories Share Price

40.18 0.60 (1.52%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×